Resources for Collectors
This page includes resources and information for the blood community regarding COVID-19 convalescent plasma, or CCP. AABB will be regularly updating this page with content. If you have resources you wish to share or see please contact AABB.
Collection of CCP can be implemented immediately by AABB-accredited blood collectors. Collection, labeling and distribution of CCP should follow the recommendations in FDA’s May 2020 Guidance document. An FDA approved IND is required for labeling of CCP and for transfusion as an investigational treatment:
Investigational COVID-19 Convalescent Plasma; Guidance for Industry (Updated May 1, 2020)